	US 11,679,091 B2
	Lymphatic circulation improving agents
Kenichi Yanagimoto, Tokyo (JP); Li Han, Tokyo (JP); and Bungo Shirouchi, Fukuoka (JP)
Assigned to Nippon Suisan Kaisha, Ltd., Tokyo (JP)
Appl. No. 16/968,321
Filed by NIPPON SUISAN KAISHA, LTD., Tokyo (JP)
PCT Filed Feb. 8, 2019, PCT No. PCT/JP2019/004588 § 371(c)(1), (2) Date Aug. 7, 2020, PCT Pub. No. WO2019/156210, PCT Pub. Date Aug. 15, 2019.
Claims priority of application No. JP2018-022378 (JP), filed on Feb. 9, 2018.
Prior Publication US 2021/0077447 A1, Mar. 18, 2021
Int. Cl. A61K 31/202 (2006.01); A23L 33/12 (2016.01); A23L 33/00 (2016.01); A61P 7/10 (2006.01); A61K 31/232 (2006.01)

CPC A61K 31/202 (2013.01) [A23L 33/12 (2016.08); A23L 33/40 (2016.08); A61K 31/232 (2013.01); A61P 7/10 (2018.01); A23V 2002/00 (2013.01)]

6 Claims

1. A method of improving lymphatic circulation for ameliorating edema, ameliorating excessive sensitivity to cold, ameliorating skin roughness, ameliorating skin dullness, mitigating stress, excreting wastes out of the body, or ameliorating disorders due to exercise, which comprises allowing a subject in need thereof to ingest an effective amount of a composition which contains a component selected from at least one highly unsaturated fatty acid, salt thereof, and ester thereof as an active ingredient, wherein the at least one highly unsaturated fatty acid is eicosapentaenoic acid or docosahexaenoic acid.